Notify me when Mubadala Investment Co PJSC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MidCap Apollo Institutional Private Lending | Common Shares of Beneficial Interest, par value $0.001 per share | 86% | 14,561,742 | Mubadala Investment Company PJSC | 30 Sep 2025 | ||||
| OTF | Blue Owl Technology Finance Corp. | Common Stock, par value $0.01 per share | 6.2% | $423,557,339 | 29,130,491 | 0% | Mubadala Investment Company PJSC | 31 Dec 2025 | |
| RXRX | RECURSION PHARMACEUTICALS, INC. | Class A Common Stock, $0.00001 par value per share | 0% | $0 | 0 | Mubadala Investment Co PJSC | 20 Nov 2024 | ||
| EDR | Endeavor Group Holdings, Inc. | Class A Common Stock, par value $0.00001 per share | 0% | $0 | 0 | Mubadala Investment Company PJSC | 24 Mar 2025 | ||
| CERT | Certara, Inc. | Common Stock, par value $0.01 per share | 0% | $0 | 0 | Mubadala Investment Company PJSC | 31 Dec 2024 | ||
| ARMN | Aris Mining Corporation | Common Shares, no par value per share | 0% | $0 | 0 | Mubadala Investment Company PJSC | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|